Preprint / Version 1

Therapeutic targeting of amino acid dependency in cancer cells

##article.authors##

  • Janelle Akpan Polygence Pods

DOI:

https://doi.org/10.58445/rars.2046

Keywords:

amino acids, cancer metabolism, nutrient dependencies, metabolic therapy

Abstract

Cancer cells often undergo changes to their metabolism when they mutate, to meet energetic and biosynthetic demands of their high proliferation rates and environment. Recent and ongoing research suggests that some of these nutrients and substances themselves can encourage oncogenic progression by altering cell signaling and blocking cellular differentiation. Such alterations in metabolism were once viewed as an indirect response to cell proliferation and survival signals, but studies show that the changes are as a direct result of modifications made for the cell to become cancerous.T o satisfy mutant changes, cancer cells often require changes made in their metabolic pathways, requiring certain nutrients to progress and causing these cells to become dependent on these nutrients. Newly developed cancer therapy, still in the experimental stages, suggests eliminating or reducing these nutrients as an effective way to disrupt cancer cell activity and eventually, kill the cells. This paper focuses on the developed methods of targeting nutrients necessary to these new metabolic pathways, as a form of cancer treatment.

References

Fan, K., Liu, Z., Gao, M., Tu, K., Xu, Q., & Zhang, Y . (2022). T argeting Nutrient Dependency

in Cancer Treatment. Frontiers in oncology, 12, 820173.

https://doi.org/10.3389/fonc.2022.820173

Ganapathy-Kanniappan, S., & Geschwind, J. F . (2013). Tumor glycolysis as a target for

cancer therapy: progress and prospects. Molecular cancer, 12, 152.

https://doi.org/10.1186/1476-4598-12-152

Pathria, G., & Ronai, Z. A. (2021). Harnessing the Co-vulnerabilities of Amino

Acid-Restricted Cancers. Cell metabolism, 33(1), 9–20.

https://doi.org/10.1016/j.cmet.2020.12.009

Garcia-Bermudez, J., Williams, R. T ., Guarecuco, R., & Birsoy, K. (2020). T argeting

extracellular nutrient dependencies of cancer cells. Molecular metabolism, 33, 67–82.

https://doi.org/10.1016/j.molmet.2019.11.011

Butler, M., van der Meer, L. T ., & van Leeuwen, F . N. (2021). Amino Acid Depletion

Therapies: Starving Cancer Cells to Death. Trends in endocrinology and metabolism: TEM,

(6), 367–381. https://doi.org/10.1016/j.tem.2021.03.003

Parmentier, J. H., Maggi, M., T arasco, E., Scotti, C., Avramis, V. I., & Mittelman, S. D. (2015).

Glutaminase activity determines cytotoxicity of L-asparaginases on most leukemia cell lines.

Leukemia research, 39(7), 757–762. https://doi.org/10.1016/j.leukres.2015.04.008

Luengo, A., Gui, D. Y ., & Vander Heiden, M. G. (2017). T argeting Metabolism for Cancer

Therapy. Cell chemical biology, 24(9), 1161–1180.

https://doi.org/10.1016/j.chembiol.2017.08.028

Song, M., Kim, S. H., Im, C. Y ., & Hwang, H. J. (2018). Recent Development of Small

Molecule Glutaminase Inhibitors. Current topics in medicinal chemistry, 18(6), 432–443.

https://doi.org/10.2174/1568026618666180525100830

Wilhelm, S. M., Adnane, L., Newell, P ., Villanueva, A., Llovet, J. M., & Lynch, M. (2008).

Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and

PDGF receptor tyrosine kinase signaling. Molecular cancer therapeutics, 7(10), 3129–3140.

https://doi.org/10.1158/1535-7163.MCT-08-0013

Gout, P . W., Buckley, A. R., Simms, C. R., & Bruchovsky, N. (2001). Sulfasalazine, a potent

suppressor of lymphoma growth by inhibition of the x(c)- cystine transporter: a new action for an

old drug. Leukemia, 15(10), 1633–1640. https://doi.org/10.1038/sj.leu.2402238

Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E.,

Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., Morrison, B., 3rd, & Stockwell, B. R.

(2012). Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell, 149(5),

–1072. https://doi.org/10.1016/j.cell.2012.03.042

Epner, D. E., Morrow, S., Wilcox, M., & Houghton, J. L. (2002). Nutrient intake and

nutritional indexes in adults with metastatic cancer on a phase I clinical trial of dietary

methionine restriction. Nutrition and cancer, 42(2), 158–166.

https://doi.org/10.1207/S15327914NC422_2

De Santo, C., Cheng, P ., Beggs, A., Egan, S., Bessudo, A., & Mussai, F . (2018). Metabolic

therapy with PEG-arginase induces a sustained complete remission in immunotherapy-resistant

melanoma. Journal of hematology & oncology, 11(1), 68.

https://doi.org/10.1186/s13045-018-0612-6

Koppula, P ., Zhuang, L., & Gan, B. (2021). Cystine transporter SLC7A11/xCT in cancer:

ferroptosis, nutrient dependency, and cancer therapy. Protein & cell, 12(8), 599–620.

https://doi.org/10.1007/s13238-020-00789-5

Downloads

Posted

2024-12-11